0001713836-18-000001.txt : 20180815 0001713836-18-000001.hdr.sgml : 20180815 20180815132742 ACCESSION NUMBER: 0001713836-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 EFFECTIVENESS DATE: 20180815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neuraptive Therapeutics, Inc. CENTRAL INDEX KEY: 0001713836 IRS NUMBER: 821914769 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319306 FILM NUMBER: 181020470 BUSINESS ADDRESS: STREET 1: 2697 TRAILRIDGE DR WEST CITY: LAFAYETTE STATE: CO ZIP: 80026 BUSINESS PHONE: 303-736-9657 MAIL ADDRESS: STREET 1: PO BOX 3441 CITY: WINTER PARK STATE: CO ZIP: 80482 D 1 primary_doc.xml X0708 D LIVE 0001713836 Neuraptive Therapeutics, Inc. 2697 TRAILRIDGE DR WEST LAFAYETTE CO COLORADO 80026 303-736-9657 DELAWARE None None Corporation true 2017 David M Jackson PO Box 3441 Winter Park CO COLORADO 80482 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-08-02 false true false 100000 100000 100000 0 false 1 0 0 0 false Neuraptive Therapeutics, Inc. David M. Jackson David M. Jackson Chief Executive Officer 2018-08-15